Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.48%||166.09||0.7%||$1108.87m|
|MRK||Merck & Co., Inc.||-0.47%||90.59||0.7%||$806.25m|
|LLY||Eli Lilly & Co.||1.90%||313.93||1.1%||$798.53m|
|BMY||Bristol-Myers Squibb Co.||-1.36%||74.54||1.0%||$648.45m|
|SIGA||SIGA Technologies, Inc.||5.66%||26.15||0.0%||$514.56m|
|GBT||Global Blood Therapeutics, Inc.||0.43%||67.04||5.6%||$334.64m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-1.21%||231.01||8.2%||$285.62m|
|HZNP||Horizon Therapeutics Plc||-3.81%||64.90||5.4%||$222.52m|
|KRTX||Karuna Therapeutics, Inc.||-1.34%||273.71||0.0%||$217.12m|
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.